Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI110625

Thromboxane Mediation of Cardiopulmonary Effects of Embolism

Takayoshi Utsunomiya, Michael M. Krausz, Lawrence Levine, David Shepro, and Herbert B. Hechtman

Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115

Harvard University School of Medicine, Boston, Massachusetts 02115

Department of Biochemistry, Brandeis University, Boston, Massachusetts 02115

Biological Science Center, Boston University, Boston, Massachusetts 02115

Find articles by Utsunomiya, T. in: PubMed | Google Scholar

Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115

Harvard University School of Medicine, Boston, Massachusetts 02115

Department of Biochemistry, Brandeis University, Boston, Massachusetts 02115

Biological Science Center, Boston University, Boston, Massachusetts 02115

Find articles by Krausz, M. in: PubMed | Google Scholar

Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115

Harvard University School of Medicine, Boston, Massachusetts 02115

Department of Biochemistry, Brandeis University, Boston, Massachusetts 02115

Biological Science Center, Boston University, Boston, Massachusetts 02115

Find articles by Levine, L. in: PubMed | Google Scholar

Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115

Harvard University School of Medicine, Boston, Massachusetts 02115

Department of Biochemistry, Brandeis University, Boston, Massachusetts 02115

Biological Science Center, Boston University, Boston, Massachusetts 02115

Find articles by Shepro, D. in: PubMed | Google Scholar

Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115

Harvard University School of Medicine, Boston, Massachusetts 02115

Department of Biochemistry, Brandeis University, Boston, Massachusetts 02115

Biological Science Center, Boston University, Boston, Massachusetts 02115

Find articles by Hechtman, H. in: PubMed | Google Scholar

Published August 1, 1982 - More info

Published in Volume 70, Issue 2 on August 1, 1982
J Clin Invest. 1982;70(2):361–368. https://doi.org/10.1172/JCI110625.
© 1982 The American Society for Clinical Investigation
Published August 1, 1982 - Version history
View PDF
Abstract

Humoral factors released from platelets during pulmonary embolism may be the cause of several attendant cardiopulmonary abnormalities. This study examines the role of thromboxanes (Tx) after experimental embolism induced with 0.5 g/kg autologous clot in four groups of five dogs: (a) untreated embolized controls; (b) pretreatment with the Tx synthetase inhibitor, imidazole 25 mg/kg · h i.v., starting 30 min before embolization; (c) pretreatment with the cyclooxygenase inhibitor indomethacin, 5 mg/kg, 12 h per os and 1 mg/kg, 1 h i.v. before the experiment; (d) treatment with prostacyclin (PGI2) 100 ηg/kg · min i.v. for 1 h, 1 h after embolization. Within 30 min, embolization led to increases of 6-keto-PGF1α, the stable hydrolysis product of PGI2, from 0.11±0.08 ηg/ml (mean±SD) to 0.33±0.10 ηg/ml (P < 0.005) and TxB2, the stable product of TxA2, from 0.10±0.04 ηg/ml to 0.38±0.06 ηg/ml (P < 0.001). Increases were observed in total dead space (VD/VT) from 0.46±0.03 to 0.61±0.08 (P < 0.025, physiologic shunting (Q̇S/Q̇T) from 16±4% to 38±9% (P < 0.01), pulmonary vascular resistance (PVR) from 2.27±0.59 mm Hg·min/liter to 9.21±1.90 mm Hg·min/liter (P < 0.005) and mean pulmonary arterial pressure from 14±6 mm Hg to 34±1 mm Hg (P < 0.001). Cardiac index (CI) fell from 139±11 ml/kg·min to 95±17 ml/kg·min in 4 h (P < 0.025). Imidazole pretreatment prevented a rise of TxB2, but not 6-keto-PGF1α; indomethacin blocked both. Both agents maintained VD/VT at base line and limited increases in Q̇S/Q̇T and PVR. CI was higher after imidazole pretreatment compared with controls (P < 0.025). Indomethacin led to intermediate levels of CI. PGI2 lowered TxB2 (P < 0.025), VD/VT (P < 0.025), Q̇S/Q̇T (P < 0.025) and PVR (P < 0.05) within 30 min. During PGI2 infusion, CI was higher than controls. Concentrations of TxB2 correlated with VD/VT, r = 0.79 and Q̇S/Q̇T, r = 0.69 (P < 0.001). Treatment of three dogs with the imidazole derivative ketoconazole, 10 mg/kg IV, 30 min after 0.75 g/kg autologous clot resulted in a lowering of physiologic dead space, but no other improvement of cardiopulmonary function. These results show that a number of cardiopulmonary abnormalities induced by pulmonary embolism are related directly or indirectly to platelet secretions and that VD/VT is closely allied to TxA2 levels.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 361
page 361
icon of scanned page 362
page 362
icon of scanned page 363
page 363
icon of scanned page 364
page 364
icon of scanned page 365
page 365
icon of scanned page 366
page 366
icon of scanned page 367
page 367
icon of scanned page 368
page 368
Version history
  • Version 1 (August 1, 1982): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts